Optimize Financial Inc Edgewise Therapeutics, Inc. Transaction History
Optimize Financial Inc
- $133 Billion
- Q4 2024
A detailed history of Optimize Financial Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Optimize Financial Inc holds 12,062 shares of EWTX stock, worth $306,254. This represents 0.24% of its overall portfolio holdings.
Number of Shares
12,062Holding current value
$306,254% of portfolio
0.24%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
212Shares Held
101MCall Options Held
1.23MPut Options Held
416K-
Orbimed Advisors LLC San Diego, CA15MShares$381 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$226 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$156 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$153 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$127 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.6B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...